Opinion|Videos|August 5, 2024
Key Takeaways on RSV Vaccination
The panel concludes its discussion by providing key takeaways on the evolving RSV vaccination landscape.
Advertisement
Episodes in this series
Video content above is prompted by the following question:
- What are your key takeaways pertaining to RSV vaccination practices?
Advertisement
Related to this article
Michael Mina, MD, PhD, of Invivyd, on measles antibody VMS063, immune amnesia, and what RSV antibody uptake signals for payers.
Advertisement
Advertisement
Trending on AJMC
1
Hepatitis B Functional Cure Persists Off Treatment After Bepirovirsen
2
Health Equity & Access Weekly Roundup: November 6, 2026
3
COPD’s Old Narrative Is Outdated, GOLD Leaders Say in 2027 Update
4
Medicaid Cuts and Caregiving in Congress: Andy Kim
5